- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03235102
Awareness, Care and Treatment in Obesity Management
Obesity ACTION Study in Canada
This study aims to assess barriers that prevent obesity patients from receiving adequate care for their condition. The non-interventional study will be administered in the form of a 30-minute, cross-sectional, online survey to various respondents. There is no experimentation involved in the process of data collection, and each survey poses minimal human risk.
The study will evaluate lifestyle habits and weight management strategies perceived and/or practiced by each of 3 stakeholders in obesity: Patients (People with obesity), Providers, and Employers. A customized survey will be administered to each of the 3 stakeholders, and data will be analyzed based on respondents' answers.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G 2E1
- Novo Nordisk Investigational Site
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria
The following inclusion criteria will be imposed for HCPs:
- Practice in Canada
- Spends at least 70% of time in direct patient care
- Seen at least 100 patients in past month
- Seen at least 10 patients in past month needing weight management
- In practice 2-35 years
- Not affiliated with Pharmaceutical, Market Research (MR) or Advertising Firms
- PCP - Physician, RN / NP / LPN, or PA, Dietitians
- PCP - Specialty is FP, IM, GP
- Obesity Specialist - Physician, RN / NP / LPN, or PA
- Obesity Specialist - Specialty is FP, IM, GP, endocrinology, bariatrics, or bariatric surgery
- Obesity Specialist - Currently practice as an obesity medicine or weight loss management specialist
The following inclusion criteria will be imposed for PwOs (people with obesity):
- Age at least 18 years
- Lives in Canada
- Recruitment will target a nationally representative Canada sample. Demographic indicators will be monitored throughout recruitment.
- Current BMI 30 kg/sqm or greater, not extremely fit/body building
- Sub-category - Maintaining weight loss: Lost at least 10% of body weight in the past 3 years and has kept weight off for at least a year
- Sub-category - Treatment Seeking: Has committed to a plan to lose weight, or has successfully lost weight (self-report) or has spoken to an HCP about weight loss plan in the last 6 months.
The following inclusion criteria will be imposed for employers:
- Age at least 18 years
- Works in a Canadian province
- Company offers health insurance
- Responsible for making or influencing decisions about health insurance or health and wellness programs
- Works in a company that has 20 or more employees
- Believes there is a weight issue (attitudinal agreement)
- Not affiliated with Pharmaceutical, Market Research (MR) or Advertising Firms
Exclusion criteria Any respondent who work works for a pharmaceutical, health insurance, research, or advertising company will be excluded; as there may be self-presentation effects that could alter the interview questions.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
People with Obesity
People with obesity, or weight loss patients.
Potential respondents will be recruited from various Internet patient panels to participate in a cross-sectional, online survey.
|
Completion of a survey
|
|
Healthcare Providers
PCPs will include family practitioners; general practitioners; internal medicine; nurse practitioners; and dietitians.
Specialists will include endocrinologists and bariatric surgeons, and any of the above if they focus on obesity treatment.
Potential respondents will be recruited from various Internet patient panels to participate in a cross-sectional, online survey.
|
Completion of a survey
|
|
Employers
Employers in Canada.
Potential respondents will be recruited from various Internet patient panels to participate in a cross-sectional, online survey.
|
Completion of a survey
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Awareness associated with the care and management of obesity among people with obesity, clinicians and employers
Time Frame: From the first interview on day 1 until the last interview on day 30
|
Cross-sectional 30-minute online survey of lifestyle habits and weight management conducted among stakeholders in obesity (clinicians, employers and people with obesity)
|
From the first interview on day 1 until the last interview on day 30
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INS-4411
- U1111-1199-1902 (Other Identifier: World Health Organization (WHO))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on No treatment given
-
Robert G. Grossman, MDThe University of Texas Health Science Center, Houston; University of Maryland... and other collaboratorsRecruitingSpinal Cord InjuryUnited States, Canada
-
Novo Nordisk A/SCompletedObesity | Overweight | Primary Prevention | Heart Failure (HF) | Atherosclerotic Cardiovascular Disease (ASCVD)United States
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SEnrolling by invitationParkinson DiseaseUnited States, Japan, Sweden, United Kingdom
-
Novo Nordisk A/SCompletedChronic Kidney Disease (CKD) | Atherosclerotic Cardiovascular Disease (ASCVD)China
-
Novo Nordisk A/SEnrolling by invitation
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedHeart Failure | Chronic Kidney Disease | Cardiovascular RiskKorea, Republic of, Italy, China, France, Canada, Sweden, India, Denmark, Czechia, Germany, Poland, Australia, Brazil, United States, Argentina, Norway, United Kingdom
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedSystemic Inflammation | Chronic Kidney Disease (CKD) | Atherosclerotic Cardiovascular Disease (ASCVD)United States